logo

For the Inventor, By the Inventor

Seoul, South Korea

Chun-Ho Lee

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Yuhan Corporation. Active years: 2013-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chun-Ho Lee. Retrieved from https://idiyas.com/inventor/chun-ho-lee-d93b3853

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 40.0

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal5 out of 97 
 
Yuhan Corporation
 patents

Years Active: 2013-2017

Loading Chart...
5 patents (USPTO):Explore Patents
1. 9663495 - Triazolone derivatives or salts thereof and pharmaceutical composition comprising the same (2017-05-30),
2. 9376420 - 4,5-dihydro-1H-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same (2016-06-28),
3. 8633223 - Process for preparation of 2-methyl-2'-phenylpropionic acid derivatives and novel intermediate compounds (2014-01-21),
4. 8487106 - Process for preparation of 2-methyl-2'-phenylpropionic acid derivatives and novel intermediate compounds (2013-07-16),
5. 8367704 - Process for preparation of 2-methyl-2' phenylpropionic acid derivatives and novel intermediate compounds (2013-02-05),

Title: Innovations of Chun-Ho Lee

Introduction

Chun-Ho Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the treatment of various medical conditions. With a total of 5 patents to his name, Lee's work is recognized for its potential impact on healthcare.

Latest Patents

One of his latest patents is focused on triazolone derivatives or salts thereof, along with a pharmaceutical composition comprising the same. This invention provides a triazolone derivative or its pharmaceutically acceptable salt, which can effectively activate GPR119. This activation is crucial as it can be applied for preventing or treating diabetes mellitus. Another notable patent involves a 4,5-dihydro-1H-pyrazole derivative or salts thereof, which also includes a pharmaceutical composition. This invention effectively increases LXR transcriptional activity, making it useful for preventing or treating dysfunctions in cholesterol metabolism, such as cholesterol gallstone, hyperlipidemia, or coronary atherosclerosis.

Career Highlights

Chun-Ho Lee is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has allowed him to focus on innovative research and development in the pharmaceutical sector.

Collaborations

Lee has collaborated with notable colleagues, including Ja-Heouk Khoo and Kyoung-Chan Kwon, to advance his research and patent applications. Their combined expertise has contributed to the successful development of new pharmaceutical compounds.

Conclusion

Chun-Ho Lee's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor in the industry. His work not only showcases his expertise but also emphasizes the importance of research in developing effective treatments for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…